Momentum in funding raised by private equity (PE) and venture capital (VC) picked up further this week, mainly propelled by a couple of big-ticket transactions ..
Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited (BZPPL), established in 2011 for pharmaceutical sales and marketing in India. Bayer is now acquiring full ownership of the entity as per pre-agreed terms. The joint venture successfully combined Zydus s Indian marketing expertise and distribution network with Bayer s global innovation, making strides in various therapeutic areas.
Biomarkers in Blood Identified to Predict Liver Cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
PharmaCyte Biotech (OTCMKTS:PMCBD – Get Free Report) and Compugen (NASDAQ:CGEN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, profitability, risk, institutional ownership and valuation. Profitability This table compares PharmaCyte Biotech and Compugen’s […]
Contrasting Compugen (NASDAQ:CGEN) and IN8bio (NASDAQ:INAB) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.